Evaluating outcomes of cervical single open-door surgery for spinal stenosis
Official title: Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery: a Multicenter Retrospective Clinical Study
Run by Xijing Hospital · NCT05767164 · Data updated 2026-11-12
This study is testing how well cervical single open-door surgery works for people with spinal stenosis who haven't found relief from other treatments, to see if understanding certain factors can help improve their outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 86 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Xijing Hospital Academic / other |
| Locations | 1 site (Xi'an, Shannxi Province) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT05767164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with typical symptoms of cervical spinal stenosis who have not benefited from conservative treatment and are scheduled for cervical single open-door surgery.
✕Probably not a fit
Patients with cervical spondylotic radiculopathy, instability, or those requiring revision surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the relationship between various evaluation parameters and the prognosis of patients undergoing cervical single open-door surgery for cervical spinal stenosis. It is a multi-center retrospective clinical study that aims to analyze complication rates and provide a theoretical basis for personalized surgical approaches. The study includes patients who have not responded to conservative treatment for at least three months and have specific MRI findings. The goal is to improve surgical outcomes through better understanding of the factors influencing prognosis.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and personalized treatment plans for patients with cervical spinal stenosis.
How similar studies have gone: Other studies have shown success with similar surgical approaches, indicating potential for meaningful advancements in treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptoms and signs of the patients were typical. MRI showed single or multiple central herniation of C3-C7 intervertebral discs or spinal stenosis at corresponding levels, which confirmed cervical myeloid cervical spondylosis or cervical spinal stenosis. * Conservative treatment for more than 3 months before surgery was ineffective. * The patients underwent cervical single open-door surgery. * Informed consent was obtained from the patient and his family, informed consent was signed, and a complete follow-up was completed after surgery Exclusion Criteria: * Cervical spondylotic radiculopathy. * Cervical kyphosis or instability. * Cervical spondylosis caused by trauma, tumor, tuberculosis and metabolic diseases. * Revision surgery or combined anterior-posterior surgery is required. * The patients had severe neurological diseases affecting the evaluation of postoperative results. * Psychopath. * MRI or CT for contraindications.
Where it's running
-
Xijing Hospital
Xi'an, Shannxi Province, China Recruiting
Study contacts
- Study coordinator: Yanyan Jia
- Email: xiyyllwyh@163.com
- Phone: +862984771794
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using barb suture in obese patients for cervical spine surgery
This study is testing whether using special barb sutures during neck surgery can help obese patients recover better and have fewer problems after their operation.
-
Individualized cervical surgery for spinal stenosis
This study tests a personalized approach to cervical surgery for people with spinal stenosis to see if it can improve safety and effectiveness.
-
Iparomlimab/Tuvonralimab with nab-paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer
This trial tests whether adding Iparomlimab/Tuvonralimab to nab-paclitaxel and cisplatin before surgery can shrink locally advanced cervical cancer and safely be given to adult women.
-
Ofatumumab for drug-refractory Narcolepsy Type 1
Aims to see if a single dose of ofatumumab helps people with Narcolepsy Type 1 who have not responded to previous treatments.
-
Drug-coated balloons vs drug-eluting stents for immediate slow-flow/no-reflow in STEMI with high thrombus
This study tests whether using a drug-coated balloon instead of a drug-eluting stent during PCI helps reduce immediate slow-flow or no-reflow in STEMI patients with high thrombus burden.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.